These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 25910491
1. Outlook for aptamers after twenty five years. Tsae PK, DeRosa MC. Curr Top Med Chem; 2015; 15(12):1153-9. PubMed ID: 25910491 [Abstract] [Full Text] [Related]
4. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases. Sriramoju B, Kanwar R, Veedu RN, Kanwar JR. Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271 [Abstract] [Full Text] [Related]
5. Aptamers as theranostic agents: modifications, serum stability and functionalisation. Shigdar S, Macdonald J, O'Connor M, Wang T, Xiang D, Al Shamaileh H, Qiao L, Wei M, Zhou SF, Zhu Y, Kong L, Bhattacharya S, Li C, Duan W. Sensors (Basel); 2013 Oct 10; 13(10):13624-37. PubMed ID: 24152925 [Abstract] [Full Text] [Related]
7. Aptamers: molecular tools for medical diagnosis. Ozalp VC, Kavruk M, Dilek O, Bayrac AT. Curr Top Med Chem; 2015 Oct 10; 15(12):1125-37. PubMed ID: 25866272 [Abstract] [Full Text] [Related]
12. Current Status and Future Prospects for Aptamer-Based Mycotoxin Detection. Ruscito A, Smith M, Goudreau DN, DeRosa MC. J AOAC Int; 2016 Jul 15; 99(4):865-877. PubMed ID: 27318356 [Abstract] [Full Text] [Related]
13. Advances and perspectives in cell-specific aptamers. Sun W, Du L, Li M. Curr Pharm Des; 2011 Jul 15; 17(1):80-91. PubMed ID: 21342116 [Abstract] [Full Text] [Related]
14. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Famulok M, Hartig JS, Mayer G. Chem Rev; 2007 Sep 15; 107(9):3715-43. PubMed ID: 17715981 [No Abstract] [Full Text] [Related]
15. Advances in screening, synthesis, modification, and biomedical applications of peptides and peptide aptamers. Liu Y, Lu X, Chen M, Wei Z, Peng G, Yang J, Tang C, Yu P. Biofactors; 2024 Sep 15; 50(1):33-57. PubMed ID: 37646383 [Abstract] [Full Text] [Related]
16. Aptamers: active targeting ligands for cancer diagnosis and therapy. Wu X, Chen J, Wu M, Zhao JX. Theranostics; 2015 Sep 15; 5(4):322-44. PubMed ID: 25699094 [Abstract] [Full Text] [Related]
17. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications. Guan B, Zhang X. Int J Nanomedicine; 2020 Sep 15; 15():1059-1071. PubMed ID: 32110008 [Abstract] [Full Text] [Related]
18. Aptamers overview: selection, features and applications. Hernandez LI, Machado I, Schafer T, Hernandez FJ. Curr Top Med Chem; 2015 Sep 15; 15(12):1066-81. PubMed ID: 25866270 [Abstract] [Full Text] [Related]
19. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics. Pangburn TO, Petersen MA, Waybrant B, Adil MM, Kokkoli E. J Biomech Eng; 2009 Jul 15; 131(7):074005. PubMed ID: 19655996 [Abstract] [Full Text] [Related]
20. Aptamer-modified nanoparticles as biosensors. Lönne M, Zhu G, Stahl F, Walter JG. Adv Biochem Eng Biotechnol; 2014 Jul 15; 140():121-54. PubMed ID: 23824145 [Abstract] [Full Text] [Related] Page: [Next] [New Search]